Yat-Gai Au received $1 in total compensation as Chief Executive Officer of Regencell Bioscience Holdings Ltd in FY2024. The largest component was $1 in base salary. Source: SEC 20-F.
In fiscal year 2024, Yat-Gai Au, Chief Executive Officer of Regencell Bioscience Holdings Ltd (RGC), received total compensation of $1.
Yat-Gai Au's compensation breakdown includes: base salary of $1,.
Regencell Bioscience Holdings Ltd's top 1 named executive officers received combined total compensation of $1 in fiscal year 2024.
The named executive officers disclosed in Regencell Bioscience Holdings Ltd's 2024 proxy statement are:Yat-Gai Au (Chief Executive Officer) with total compensation of $1.
Yat-Gai Au, Chief Executive Officer of Regencell Bioscience Holdings Ltd (RGC), received $1 in total compensation for FY2024. Base salary of $1 was the largest component. Figures come from Regencell Bioscience Holdings Ltd's 20-F 0001213900-24-090791 filed 25 Oct 2024.
Source Filing
Executive Record
Yat-Gai Au
Chief Executive Officer
Reported Pay
$1Summary compensation table total · FY2024
Read the board's pay decision against shareholder returns and current filing context.
Regencell Bioscience Holdings Ltd (RGC) — Key Facts
Last updated Mar 13, 2026 · 20-F filed Oct 25, 2024
| CEO | Yat-Gai Au, Chief Executive Officer |
|---|---|
| Fiscal year | FY2024 |
| Total compensation | $1 |
| Base salary | $1 |
| Source | 20-F, 2024-10-25 |
Yat-Gai Au, the Chief Executive Officer of Regencell Bioscience Holdings Ltd, received total compensation of $1 in fiscal year 2024. This includes base salary of $1. Figures come from Regencell Bioscience Holdings Ltd's 20-F 0001213900-24-090791 filed 25 Oct 2024.
Yat-Gai Au's base salary at Regencell Bioscience Holdings Ltd is $1 per year as of fiscal year 2024. However, total compensation including stock awards, bonuses, and other benefits is $1. Figures come from Regencell Bioscience Holdings Ltd's 20-F 0001213900-24-090791 filed 25 Oct 2024.
Regencell Bioscience Holdings Ltd's CEO, Yat-Gai Au, earned $1 in total compensation for fiscal year 2024. Figures come from Regencell Bioscience Holdings Ltd's 20-F 0001213900-24-090791 filed 25 Oct 2024.
Reading filings for RGC...
Reading the latest proxy statement
Calculating CEO-to-worker ratio
Checking insider sales and trading plans